AX
Axcella Health Inc. (AXLA) NASDAQ Global Market · Currency in USD
$4.58 ▲ +0.00 (+0.00%)
At close: Jan 16, 4:00 PM ET. Market closed.
1D 5D 1M 6M YTD 1Y 5Y Max
Line Candles
Summary
Previous Close $4.58
Open $0.36
Day's Range $0.36 – $4.58
52 Week Range $0.36 – $4.58
Volume 6,782
Avg. Volume 37,076
Market Cap $12.50M
Beta (5Y Monthly) 0.58
PE Ratio (TTM) --
EPS (TTM) -$1.27
Earnings Date --
Forward Dividend & Yield --
Ex-Dividend Date --
1y Target Est $60.00
Profile: Axcella Health Inc.
Sector Healthcare
Industry Biotechnology
Full-time employees 11
CEO Craig R. Jalbert CIRA
Axcella Health Inc. is a U.S.-based clinical-stage biotechnology firm focused on developing novel therapeutic compositions derived from endogenous metabolic modulators. These aim to address complex diseases and improve overall health. The company's primary drug candidates are AXA1665 and AXA1125.
Earnings
Date Est. Actual
Aug 3, 2023 -$0.06 -$1.25 Miss
May 4, 2023 -$0.16 -$0.05 Beat
Mar 30, 2023 -$0.25 -$7.75 Miss
Nov 1, 2022 -$0.38 -$0.34 Beat
Aug 12, 2022 -$0.38 -$0.42 Miss
May 5, 2022 -$0.39 -$0.46 Miss
Analyst view
Consensus price target
$60.00 ▲ +1,210.0%
Range $60.00 – $60.00
Rating: Buy
Buy 60% · Hold 30% · Sell 10%
Get free alerts on AXLA and big market moves
Free special alerts by text & email on new investment opportunities, buyouts and the stocks moving most, in plain English.
Get free stock alerts →
Data: Financial Modeling Prep. For information only, not investment advice.